These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 26743321)

  • 1. Direct oral anticoagulants in antiphospholipid syndrome: a real life case series.
    Betancur JF; Bonilla-Abadía F; Hormaza AA; Jaramillo FJ; Cañas CA; Tobón GJ
    Lupus; 2016 May; 25(6):658-62. PubMed ID: 26743321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K; Góralczyk T; Undas A
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
    Dufrost V; Risse J; Zuily S; Wahl D
    Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulants in hypercoagulable states.
    Kunk PR; Brown J; McShane M; Palkimas S; Gail Macik B
    J Thromb Thrombolysis; 2017 Jan; 43(1):79-85. PubMed ID: 27632140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
    Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
    Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of direct oral anticoagulants in antiphospholipid syndrome.
    Cohen H; Efthymiou M; Isenberg DA
    J Thromb Haemost; 2018 Jun; 16(6):1028-1039. PubMed ID: 29624847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apixaban Versus Vitamin K Antagonists in Patients With Antiphospholipid Syndrome: A Cohort Study.
    Sikorska M; Chmiel J; Papuga-Szela E; Broniatowska E; Undas A
    J Cardiovasc Pharmacol; 2024 Jul; 84(1):36-44. PubMed ID: 38922590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
    Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study.
    Malec K; Broniatowska E; Undas A
    Lupus; 2020 Jan; 29(1):37-44. PubMed ID: 31757182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: Study Rationale and Design (ASTRO-APS).
    Woller SC; Stevens SM; Kaplan DA; Branch DW; Aston VT; Wilson EL; Gallo HM; Johnson EG; Rondina MT; Lloyd JF; Evans RS; Elliott CG
    Clin Appl Thromb Hemost; 2016 Apr; 22(3):239-47. PubMed ID: 26566669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.
    Ruiz-Irastorza G; Khamashta MA; Hunt BJ; Escudero A; Cuadrado MJ; Hughes GR
    Arch Intern Med; 2002 May; 162(10):1164-9. PubMed ID: 12020188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.
    Pengo V; Banzato A; Bison E; Zoppellaro G; Padayattil Jose S; Denas G
    Lupus; 2016 Mar; 25(3):301-6. PubMed ID: 26466613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of anticoagulation in patients with low risk antiphospholipid syndrome.
    Bakow BR; Phung Q; Rabinovich D; Olszewski AJ; Reagan JL
    J Thromb Thrombolysis; 2023 Jul; 56(1):121-127. PubMed ID: 37219825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent Thrombosis in Patients with Antiphospholipid Syndrome Receiving Newer Oral Anticoagulants: A Case Report and Review of Literature.
    Joshi A; Hong J; Siva C
    Clin Med Res; 2017 Jun; 15(1-2):41-44. PubMed ID: 28751467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing APLS and oranges: caution with the use of direct-acting oral anticoagulants (DOACs) instead of warfarin in the treatment of antiphospholipid syndrome (APLS).
    Benger M; Vink J; Snell LB; Breen K
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30940667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of Literature.
    Al Sulaiman K; Hafiz A; Badreldin HA; Korayem GB; Alsuwayyid F; Alrashidi PharmD A; Alhijris M; Almutairi PharmD F; Alharthi F; Alghamdi S; Abu Alreesh A; Aljuhani O
    J Investig Med High Impact Case Rep; 2022; 10():23247096221099893. PubMed ID: 35593449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cessation of oral anticoagulants in antiphospholipid syndrome.
    Comarmond C; Jego P; Veyssier-Belot C; Marie I; Mekinian A; Elmaleh-Sachs A; Leroux G; Saadoun D; Oziol E; Fraisse T; Hyvernat H; Thiercein-Legrand MF; Sarrot-Reynauld F; Ferreira-Maldent N; de Menthon M; Goujard C; Khau D; Nguen Y; Monnier S; Michon A; Castel B; Decaux O; Piette JC; Cacoub P
    Lupus; 2017 Oct; 26(12):1291-1296. PubMed ID: 28355985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct oral anticoagulants in antiphospholipid syndrome: Meta-analysis of randomized controlled trials.
    Dufrost V; Wahl D; Zuily S
    Autoimmun Rev; 2021 Jan; 20(1):102711. PubMed ID: 33197580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.
    Draper E; Parkhurst B; Carley B; Krueger K; Larson T; Griesbach S
    Am J Cardiovasc Drugs; 2017 Dec; 17(6):475-479. PubMed ID: 28887621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recurrent thromboses and hemorrhagic complications in patients with antiphospholipid syndrome during therapy with warfarin plus aspirin].
    Kondrat'eva LV; Patrusheva NL; Patrushev LI; Aleksandrova EN; Kovalenko TF; Ostriakova EV; Reshetniak TM
    Ter Arkh; 2010; 82(5):33-9. PubMed ID: 20597268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.